B99Looks like you didnot read the full news.This time will be a binding cash offer not non binding. No more than 10 due diligence days.Better to read carefully before post.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%